2024 Q1 Form 10-K Financial Statement

#000168316824002011 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $1.131M $1.366M $5.611M
YoY Change -13.6% -5.4% -25.47%
Cost Of Revenue $226.0K $290.0K $1.257M
YoY Change -27.8% -46.3% -62.52%
Gross Profit $905.0K $1.076M $4.354M
YoY Change -9.14% 19.03% 4.29%
Gross Profit Margin 80.02% 78.77% 77.6%
Selling, General & Admin $2.358M $2.326M $10.84M
YoY Change -27.31% -34.42% -22.5%
% of Gross Profit 260.55% 216.17% 249.06%
Research & Development $1.019M $1.138M $5.556M
YoY Change -43.26% -39.24% -14.06%
% of Gross Profit 112.6% 105.76% 127.61%
Depreciation & Amortization $438.0K $449.0K $1.659M
YoY Change 10.33% 17.23% 26.83%
% of Gross Profit 48.4% 41.73% 38.1%
Operating Expenses $3.377M $3.464M $16.40M
YoY Change -33.0% -36.09% -19.84%
Operating Profit -$2.472M -$2.388M -$12.05M
YoY Change -38.87% -47.12% -26.02%
Interest Expense $228.0K -$429.0K -$1.845M
YoY Change -68.81% -36.73% -178.21%
% of Operating Profit
Other Income/Expense, Net -$6.000K
YoY Change -114.63%
Pretax Income -$1.716M -$2.817M -$13.89M
YoY Change -63.75% -45.76% -14.41%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.716M -$2.817M -$13.89M
YoY Change -63.75% -45.76% -14.41%
Net Earnings / Revenue -151.72% -206.22% -247.57%
Basic Earnings Per Share -$0.94 -$11.46
Diluted Earnings Per Share -$0.94 -$1.79 -$11.46
COMMON SHARES
Basic Shares Outstanding 1.945M shares 34.40M shares 1.212M shares
Diluted Shares Outstanding 1.865M shares 1.212M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $122.0K $139.0K $139.0K
YoY Change -70.32% -95.39% -95.39%
Cash & Equivalents $122.0K $139.0K $139.0K
Short-Term Investments
Other Short-Term Assets $385.0K $331.0K $331.0K
YoY Change 3.49% -82.37% -82.37%
Inventory
Prepaid Expenses
Receivables $256.0K $668.0K $668.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $763.0K $1.138M $1.138M
YoY Change -39.11% -79.01% -79.01%
LONG-TERM ASSETS
Property, Plant & Equipment $3.013M $4.939M $4.939M
YoY Change 20.28% 128.87% 33.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $171.0K $171.0K $171.0K
YoY Change 21.28% 19.58% 19.58%
Total Long-Term Assets $4.969M $5.110M $5.110M
YoY Change 25.64% 32.62% 32.62%
TOTAL ASSETS
Total Short-Term Assets $763.0K $1.138M $1.138M
Total Long-Term Assets $4.969M $5.110M $5.110M
Total Assets $5.732M $6.248M $6.248M
YoY Change 10.06% -32.64% -32.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.893M $2.215M $2.215M
YoY Change 25.28% 74.0% 74.0%
Accrued Expenses $356.0K $400.0K $400.0K
YoY Change -32.06% -10.31% -45.95%
Deferred Revenue $915.0K $439.0K
YoY Change 451.2% -3.52%
Short-Term Debt $1.724M $10.82M $10.82M
YoY Change -83.94% 7.01% 7.01%
Long-Term Debt Due $284.0K $384.0K $384.0K
YoY Change -56.84% -42.43% -42.43%
Total Short-Term Liabilities $5.419M $14.26M $14.26M
YoY Change -60.83% 7.64% 7.64%
LONG-TERM LIABILITIES
Long-Term Debt $2.000K $3.000K $3.000K
YoY Change -60.0% -70.0% -70.0%
Other Long-Term Liabilities $1.480M $1.539M $1.539M
YoY Change 643.72% 566.23% 566.23%
Total Long-Term Liabilities $1.482M $1.542M $1.542M
YoY Change 626.47% 539.83% 539.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.419M $14.26M $14.26M
Total Long-Term Liabilities $1.482M $1.542M $1.542M
Total Liabilities $6.901M $15.80M $15.80M
YoY Change -50.85% 17.15% 17.15%
SHAREHOLDERS EQUITY
Retained Earnings -$111.9M -$110.2M
YoY Change 10.76% 14.42%
Common Stock $19.00K $18.00K
YoY Change -91.04% -91.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.169M -$9.555M -$9.555M
YoY Change
Total Liabilities & Shareholders Equity $5.732M $6.248M $6.248M
YoY Change 10.06% -32.64% -32.64%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.716M -$2.817M -$13.89M
YoY Change -63.75% -45.76% -14.41%
Depreciation, Depletion And Amortization $438.0K $449.0K $1.659M
YoY Change 10.33% 17.23% 26.83%
Cash From Operating Activities -$1.114M -$2.987M -$7.767M
YoY Change -51.82% -17.78% -41.11%
INVESTING ACTIVITIES
Capital Expenditures $64.00K $408.0K $1.448M
YoY Change 1500.0% 11.48% 371.66%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$427.0K -$408.0K -$1.448M
YoY Change 41.86% 11.48% -2.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $7.034M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.524M 3.359M 6.339M
YoY Change 16833.33% 3010.19% -53.33%
NET CHANGE
Cash From Operating Activities -$1.114M -2.987M -7.767M
Cash From Investing Activities -$427.0K -408.0K -1.448M
Cash From Financing Activities $1.524M 3.359M 6.339M
Net Change In Cash -$17.00K -36.00K -2.876M
YoY Change -99.35% -99.07% 165.07%
FREE CASH FLOW
Cash From Operating Activities -$1.114M -$2.987M -$7.767M
Capital Expenditures $64.00K $408.0K $1.448M
Free Cash Flow -$1.178M -$3.395M -$9.215M
YoY Change -49.14% -15.1% -31.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000736012
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 intz Restricted Stock Awards
RestrictedStockAwards
usd
CY2023 intz Restricted Stock Awards
RestrictedStockAwards
usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3015000 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39608
CY2023 dei Entity Registrant Name
EntityRegistrantName
INTRUSION INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-1911917
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
101 EAST PARK BLVD
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 1200
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
PLANO
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75074
CY2023 dei City Area Code
CityAreaCode
972
CY2023 dei Local Phone Number
LocalPhoneNumber
234-6400
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023 dei Trading Symbol
TradingSymbol
INTZ
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
24958545 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1944675 shares
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
726
CY2023 dei Auditor Name
AuditorName
Whitley Penn LLP
CY2023 dei Auditor Location
AuditorLocation
Dallas, Texas
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3015000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
364000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
530000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
635000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1877000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1138000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5422000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2069000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2865000 usd
CY2023Q4 intz Capitalized Software Development Gross
CapitalizedSoftwareDevelopmentGross
2791000 usd
CY2022Q4 intz Capitalized Software Development Gross
CapitalizedSoftwareDevelopmentGross
1380000 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
0 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
15000 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
78000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4875000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4366000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1955000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2208000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2920000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2158000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
382000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1048000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1637000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
504000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
171000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
5110000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3853000 usd
CY2023Q4 us-gaap Assets
Assets
6248000 usd
CY2022Q4 us-gaap Assets
Assets
9275000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2215000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1273000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
222000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
446000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
384000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
667000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
178000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
294000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
10823000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
10114000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
439000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
455000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14261000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13249000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1539000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
231000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1542000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
241000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1791000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1060000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1790000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1059000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
11000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1000 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
362000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
362000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101049000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92505000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110217000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96326000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9555000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4215000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6248000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9275000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5611000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7529000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1257000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3354000 usd
CY2023 us-gaap Gross Profit
GrossProfit
4354000 usd
CY2022 us-gaap Gross Profit
GrossProfit
4175000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5670000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6510000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5556000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6465000 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
43000 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
2028000 usd
CY2023 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
385000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13891000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16229000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.46
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-16.39
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.46
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-16.39
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1212000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
990000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1212000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
990000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3919000 usd
CY2022 intz Registered Direct Offering Proceeds Net Of Fees
RegisteredDirectOfferingProceedsNetOfFees
4296000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1985000 usd
CY2022 intz Issuance Of Common Stock To Terminate Operating Lease
IssuanceOfCommonStockToTerminateOperatingLease
200000 usd
CY2022 intz Nonregistered Private Placement
NonregisteredPrivatePlacement
100000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1456000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000 usd
CY2022 intz Tax Withholdings Related To Stockbased Compensation Awards
TaxWithholdingsRelatedToStockbasedCompensationAwards
-9000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16229000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4215000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
972000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4678000 usd
CY2023 intz Withholdings Related To Stockbased Compensation Awards
WithholdingsRelatedToStockbasedCompensationAwards
-5000 usd
CY2023 intz Stock Issued During Period Value New Issues Private
StockIssuedDuringPeriodValueNewIssuesPrivate
2346000 usd
CY2023 intz Issuance Of Common Stock To Reduce Notes Payable
IssuanceOfCommonStockToReduceNotesPayable
550000 usd
CY2023 intz Purchase Of Common Stock Through Employee Stock Purchase Plan
PurchaseOfCommonStockThroughEmployeeStockPurchasePlan
2000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13891000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9555000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-13891000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16229000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1659000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1308000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
69000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
972000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1456000 usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
328000 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
304000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
496000 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
861000 usd
CY2023 intz Noncash Interest On Notes Payable
NoncashInterestOnNotesPayable
1163000 usd
CY2022 intz Noncash Interest On Notes Payable
NoncashInterestOnNotesPayable
1463000 usd
CY2023 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-0 usd
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
385000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-97000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-504000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1214000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1533000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
411000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
206000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-269000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1040000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-16000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-105000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7767000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13190000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
157000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
307000 usd
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1291000 usd
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1172000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1448000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1479000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000000 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
710000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
400000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1500000 usd
CY2023 intz Reduction Of Finance Lease Liability
ReductionOfFinanceLeaseLiability
290000 usd
CY2022 intz Reduction Of Finance Lease Liability
ReductionOfFinanceLeaseLiability
645000 usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
4678000 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1985000 usd
CY2023 intz Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
2346000 usd
CY2022 intz Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
0 usd
CY2023 intz Proceeds From Registered Direct Offering Net Of Fees
ProceedsFromRegisteredDirectOfferingNetOfFees
0 usd
CY2022 intz Proceeds From Registered Direct Offering Net Of Fees
ProceedsFromRegisteredDirectOfferingNetOfFees
4296000 usd
CY2023 intz Proceeds From Nonregistered Private Placement
ProceedsFromNonregisteredPrivatePlacement
0 usd
CY2022 intz Proceeds From Nonregistered Private Placement
ProceedsFromNonregisteredPrivatePlacement
100000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
67000 usd
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2000 usd
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
CY2023 intz Withholdings Related To Stockbased Compensation Award
WithholdingsRelatedToStockbasedCompensationAward
5000 usd
CY2022 intz Withholdings Related To Stockbased Compensation Award
WithholdingsRelatedToStockbasedCompensationAward
9000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6339000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13584000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2876000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1085000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3015000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4100000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3015000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
229000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
35000 usd
CY2023 intz Capitalized Assets And Capitalized Software Included In Accounts Payable
CapitalizedAssetsAndCapitalizedSoftwareIncludedInAccountsPayable
307000 usd
CY2022 intz Capitalized Assets And Capitalized Software Included In Accounts Payable
CapitalizedAssetsAndCapitalizedSoftwareIncludedInAccountsPayable
261000 usd
CY2023 intz Common Stock Issued For Lease Termination
CommonStockIssuedForLeaseTermination
0 usd
CY2022 intz Common Stock Issued For Lease Termination
CommonStockIssuedForLeaseTermination
200000 usd
CY2023 intz Common Stock Issued To Reduce Notes Payable
CommonStockIssuedToReduceNotesPayable
550000 usd
CY2022 intz Common Stock Issued To Reduce Notes Payable
CommonStockIssuedToReduceNotesPayable
0 usd
CY2023 intz Assets Acquired Under Right Of Use Rou Operating Lease
AssetsAcquiredUnderRightOfUseRouOperatingLease
1461000 usd
CY2022 intz Assets Acquired Under Right Of Use Rou Operating Lease
AssetsAcquiredUnderRightOfUseRouOperatingLease
0 usd
CY2023 intz Assets Acquired Under Rou Finance Lease
AssetsAcquiredUnderRouFinanceLease
0 usd
CY2022 intz Assets Acquired Under Rou Finance Lease
AssetsAcquiredUnderRouFinanceLease
5000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
100000 usd
CY2023Q4 intz Working Capital
WorkingCapital
-13100000 usd
CY2023Q1 intz Changes In Working Captial
ChangesInWorkingCaptial
1400000 usd
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split of 1-for-20
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zdxYvpNKtOPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_869_ze2HUvoqVm61">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but not limited to, the accounting for credit losses, revenue recognition, warranty costs, depreciation, and stock-based compensation and income taxes. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
400000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
500000 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1000000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
100000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zvYO0dnOLeNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86B_zT0lFkgxgBwl">Risk Concentration</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, investments, and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, the Company places its investments in U.S. government obligations, corporate securities, and money market funds. Substantially all the Company’s cash, cash equivalents and investments are maintained with one major U.S. financial institution. The Company does not believe that it is subject to any unusual financial risk with the Company’s banking arrangements. The Company has not experienced any significant losses on its cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company sells its products to customers primarily in the U.S. The Company has begun to sell the Company’s products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company’s operating results. The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral. The Company maintains reserves for potential credit losses, and such losses, in aggregate, have historically been minimal.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s operations are concentrated in one area - security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20231231__srt--MajorCustomersAxis__custom--SixGovernmentCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zp4QKXjw7Luk">46.2</span>% of total revenues attributable to six government customers and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--SevenGovernmentCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdcS6pYFarki">65.8</span>% of total revenues attributable to seven government customers for the years ended December 31, 2023, and 2022, respectively. Two individual government customers and two individual commercial customers during the year ended December 31, 2023, individually accounted for over 10% of total revenues and during the year ended December 31, 2022, three government customers and two commercial customers, individually accounted for over 10% of total revenues. For 2023, four customers represent <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20231231__srt--MajorCustomersAxis__custom--FourCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zuGxBSMqT18h">86</span>% of total revenue. For 2022, five customers represent <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--FiveCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNfazPZNepGh">90</span>% of total revenue. For <b><i>Shield</i></b>, one customer accounts for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20231231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ShieldRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zakimboQjxJ3">79</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ShieldRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ztPrCJ5M4Pxe">68</span>% of <b><i>Shield</i></b> revenue for 2023 and 2022, respectively. The Company’s similar product and service offerings are not viewed as individual segments, as the Company’s management analyzes the business as a whole and expenses are not allocated to each product offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023 us-gaap Depreciation
Depreciation
1000000 usd
CY2022 us-gaap Depreciation
Depreciation
600000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
400000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
500000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
100000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
455000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
560000 usd
CY2023 intz Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
4727000 usd
CY2022 intz Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1877000 usd
CY2023 intz Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
-4743000 usd
CY2022 intz Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
-1982000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
439000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
455000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
100000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
500000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
182000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66000 shares
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
304000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
143000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
107000 usd
CY2023Q4 intz Prepaid Licenses
PrepaidLicenses
14000 usd
CY2022Q4 intz Prepaid Licenses
PrepaidLicenses
98000 usd
CY2023Q4 intz Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
0 usd
CY2022Q4 intz Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
1363000 usd
CY2023Q4 intz Prepaid Other
PrepaidOther
174000 usd
CY2022Q4 intz Prepaid Other
PrepaidOther
309000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
635000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1877000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
189000 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
141000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
195000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
23000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
36000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
52000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
222000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
446000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
382000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1048000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1637000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
504000 usd
CY2023Q4 intz Lease Assets
LeaseAssets
2019000 usd
CY2022Q4 intz Lease Assets
LeaseAssets
1552000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
384000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
667000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
178000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
294000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1539000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
231000 usd
CY2023Q4 intz Lease Liabilities
LeaseLiabilities
2104000 usd
CY2022Q4 intz Lease Liabilities
LeaseLiabilities
1202000 usd
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M29D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y7M28D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0332 pure
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0337 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0767 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0342 pure
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
666000 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
665000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
329000 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
304000 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
13000 usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
35000 usd
CY2023 intz Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
1008000 usd
CY2022 intz Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
1004000 usd
CY2023 intz Operating Cash Flows For Operating Leases
OperatingCashFlowsForOperatingLeases
-261000 usd
CY2022 intz Operating Cash Flows For Operating Leases
OperatingCashFlowsForOperatingLeases
-1085000 usd
CY2023 intz Financing Cash Flows For Finance Leases
FinancingCashFlowsForFinanceLeases
-290000 usd
CY2022 intz Financing Cash Flows For Finance Leases
FinancingCashFlowsForFinanceLeases
-645000 usd
CY2023Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Twelve Months
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingTwelveMonths
694000 usd
CY2023Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Two
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearTwo
259000 usd
CY2023Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Three
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearThree
196000 usd
CY2023Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Four
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFour
165000 usd
CY2023Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling Year Five
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFive
223000 usd
CY2023Q4 intz Lessee Operating And Finance Lease Liability Payments Due In Rolling After Year Five
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive
1517000 usd
CY2023Q4 intz Lessee Operating And Finance Lease Liability Payments Due
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue
3054000 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
1700000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
2300000 usd
CY2022Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
3300000 usd
CY2023Q4 us-gaap Payments For Fees
PaymentsForFees
300000 usd
CY2023Q4 us-gaap Payments For Reinsurance
PaymentsForReinsurance
300000 usd
CY2023Q4 intz Paid Retention Was Exhausted
PaidRetentionWasExhausted
500000 usd
CY2023Q4 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
144000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
8000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
57.60
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
11000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
26.20
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
8000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
56.60
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-0 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
11000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
28.20
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
104.40
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
129.40
CY2023 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
31000 shares
CY2023 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
24.80
CY2022 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
17000 shares
CY2022 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
72.60
CY2023 intz Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
-4000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.60
CY2022 intz Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
-5000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.40
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
86.40
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
163.20
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
156.00
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
269.40
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
50000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
62.40
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
104.40
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
23000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
85.60
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
82.60
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
323000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-419000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
50000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
23000 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y9M21D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M23D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
62.40
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
85.60
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.60
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
66.40
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0368 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0217 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.1417 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2954 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M8D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y9M3D
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000 usd
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-109000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-107000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-427000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
89000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-211000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5899000 usd
CY2023 intz Expiring Federal Net Operating Losses
ExpiringFederalNetOperatingLosses
3341000 usd
CY2022 intz Expiring Federal Net Operating Losses
ExpiringFederalNetOperatingLosses
9745000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15998000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15994000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
56000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
56000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
182000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
73000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
528000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
349000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
546000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
830000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16946000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17156000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16946000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17156000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2917000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3409000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
76100000 usd
CY2022Q4 intz Erc Receivable
ERCReceivable
1400000 usd
CY2023Q1 intz Proceeds From Employee Retention Credit
ProceedsFromEmployeeRetentionCredit
1400000 usd

Files In Submission

Name View Source Status
0001683168-24-002011-index-headers.html Edgar Link pending
0001683168-24-002011-index.html Edgar Link pending
0001683168-24-002011.txt Edgar Link pending
0001683168-24-002011-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_037.jpg Edgar Link pending
image_038.jpg Edgar Link pending
image_039.jpg Edgar Link pending
image_040.jpg Edgar Link pending
image_041.jpg Edgar Link pending
image_042.jpg Edgar Link pending
image_043.jpg Edgar Link pending
image_044.jpg Edgar Link pending
image_045.jpg Edgar Link pending
image_046.jpg Edgar Link pending
image_047.jpg Edgar Link pending
image_054.jpg Edgar Link pending
image_055.jpg Edgar Link pending
image_056.jpg Edgar Link pending
image_057.jpg Edgar Link pending
image_058.jpg Edgar Link pending
image_059.jpg Edgar Link pending
image_060.jpg Edgar Link pending
image_061.jpg Edgar Link pending
image_062.jpg Edgar Link pending
image_063.jpg Edgar Link pending
image_064.jpg Edgar Link pending
image_065.jpg Edgar Link pending
image_066.jpg Edgar Link pending
image_067.jpg Edgar Link pending
image_068.jpg Edgar Link pending
image_069.jpg Edgar Link pending
image_070.jpg Edgar Link pending
image_071.jpg Edgar Link pending
image_072.jpg Edgar Link pending
image_073.jpg Edgar Link pending
image_074.jpg Edgar Link pending
image_075.jpg Edgar Link pending
image_076.jpg Edgar Link pending
image_077.jpg Edgar Link pending
image_078.jpg Edgar Link pending
image_079.jpg Edgar Link pending
image_080.jpg Edgar Link pending
image_081.jpg Edgar Link pending
image_082.jpg Edgar Link pending
image_083.jpg Edgar Link pending
image_084.jpg Edgar Link pending
image_085.jpg Edgar Link pending
image_086.jpg Edgar Link pending
image_087.jpg Edgar Link pending
image_088.jpg Edgar Link pending
image_089.jpg Edgar Link pending
image_090.jpg Edgar Link pending
image_092.jpg Edgar Link pending
image_093.jpg Edgar Link pending
image_094.jpg Edgar Link pending
image_095.jpg Edgar Link pending
image_096.jpg Edgar Link pending
intrusion_ex1035.htm Edgar Link pending
intrusion_ex2301.htm Edgar Link pending
intrusion_ex3101.htm Edgar Link pending
intrusion_ex3102.htm Edgar Link pending
intrusion_ex3201.htm Edgar Link pending
intrusion_ex3202.htm Edgar Link pending
intrusion_ex97.htm Edgar Link pending
intrusion_i10k-123123.htm Edgar Link pending
intz-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
intz-20231231_lab.xml Edgar Link unprocessable
intrusion_i10k-123123_htm.xml Edgar Link completed
intz-20231231_pre.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
intz-20231231_cal.xml Edgar Link unprocessable
intz-20231231_def.xml Edgar Link unprocessable